GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16520
Submission : 2003-04-07
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25553
Submission : 2011-12-01
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29223
Submission : 2015-03-11
Status : Active
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29223
Submission : 2015-03-11
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16520
Submission : 2003-04-07
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25553
Submission : 2011-12-01
Status : Active
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FINISHED DOSAGE FORMULATIONS
Drug : OMEGAVEN
Dosage Form : EMULSION; INTRAVENOUS
Application Number : 210589
Country : US
Patented : Yes

FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL
Drug : SMOFLIPID 20%
Dosage Form : EMULSION; INTRAVENOUS
Application Number : 207648
Country : US
Patented : No

Drug : CINVANTI
Dosage Form : EMULSION; INTRAVENOUS
Application Number : 209296
Country : US
Patented : Yes

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SODIUM OLEATE
Route : INTRAVENOUS
CAS : 143-19-1
UNII : 399SL044HN
Potency Amount : 0.03
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
MARKET PLACE